Skip to content
Search

Latest Stories

London university trial to look at whether Vitamin D can protect against Covid

Queen Mary University of London has launched a study to see if vitamin D can offer any protection against Covid-19.

The 'Coronavit' trial funded by Barts Charity will test whether higher doses of vitamin D might offer protection against winter respiratory infections including Covid-19.


The research project will run for six months and involve more than 5,000 people, each of whom will take part in the study from their homes as all vitamin D tests and supplements will be sent via the post.

UK residents aged 16 and over can participate in the trial as long as they are not already taking high-dose vitamin D.

Lead researcher Professor Adrian Martineau from Queen Mary University of London said: “There is mounting evidence that vitamin D might reduce the risk of respiratory infections, with some recent studies suggesting that people with lower vitamin D levels may be more susceptible to coronavirus."

The intervention to be evaluated involves a postal finger prick vitamin D test, which will be processed in an NHS lab. Participants who are found to have low levels of vitamin D in their blood will then be given a six months’ supply of either 800 or 3,200 IU of vitamin D a day.

The research team will then track the incidence of doctor-diagnosed or laboratory-confirmed acute respiratory infection in the participants, including Covid-19, to see whether vitamin D supplementation has had an effect on their risk and severity of infection.

Principal investigator of the study, Dr David Jolliffe from Queen Mary University of London, added: “Coronavit trial has the potential to give a definitive answer to the question of whether vitamin D offers protection against Covid-19. Vitamin D supplements are low in cost, low in risk and widely accessible; if proven effective, they could significantly aid in our global fight against the virus.”

Meanwhile, a new review by the National Institute for Health and Care Excellence (NICE) in July had concluded that there was no evidence to support taking vitamin D supplements to specifically prevent or treat Covid-19.

More For You

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard, who is set to step down as NHS England chief in April, has been appointed as the next chief executive of Guy’s and St Thomas’ NHS Foundation Trust.

Pritchard previously led the Trust from October 2015 to August 2019 before moving to NHS England, where she later became its first female chief executive in August 2021.

Keep ReadingShow less
Confirm Pharmacy First Funding beyond April- Helen Morgan MP urges health secretary

North Shropshire MP Helen Morgan

Helen Morgan MP calls on Wes Streeting to clarify Pharmacy First’s future

Liberal Democrat health and care spokesperson Helen Morgan has urged the government to provide clarity on the future of Pharmacy First and confirm continued funding beyond April.

In a letter to health secretary Wes Streeting, the North Shropshire MP expressed deep concern over the uncertainty surrounding the initiative, which plays a crucial role in shifting healthcare services into communities.

Keep ReadingShow less
NHS England restructures leadership with new executive team

Except for the deputy chief executive officer, all team members will assume their roles on 1 April 2025.

Getty Images

NHS England announces new executive team to lead transformation

Sir James Mackey will be leading NHS England’s transition into the Department of Health and Social Care (DHSC), along with the incoming team.

He will officially take up the role as the new chief executive officer of NHS England on 1 April 2025, replacing Amanda Pritchard, who is stepping down at the end of this month.

Keep ReadingShow less
Community Pharmacies advised to reduce opening hours and services

Community Pharmacies advised to reduce opening hours and services

Breaking news: Pharmacies advised to reduce opening hours and services from April 1st

The government has been warned that community pharmacies will take collective action and reduce opening hours and services from April 1st unless there is an imminent clarity on a new funding contract.

The National Pharmacy Association (NPA) on Tuesday (17) announced that will advise its 6000 member pharmacies in England to take the unprecedented step in the face of what it has described as an April cliff-edge that will see a range of financial burdens placed on the sector.

Keep ReadingShow less
More patients on weight-loss injections undergoing gallbladder removal, warns pharmacist

Weight-loss injections can make bile more sludgy and even lead to the formation of gallstones

GettyImages

Weight-loss injections can cause gallstones, warns pharmacist

A leading pharmacist has raised concerns over a rise in gallbladder issues among individuals using weight-loss injections, particularly Eli Lilly’s Mounjaro (tirzepatide).

Deborah Grayson, a pharmacist and nutritional therapist, shared an alert in a TikTok video, highlighting the potential effects of weight-loss injections on gallbladder health.

Keep ReadingShow less